HSBC Holdings’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$686K Buy
+9,643
New +$674K ﹤0.01% 2059
2025
Q4
Sell
-3,521
Closed -$210K 3152
2025
Q3
$210K Sell
3,521
-1,789
-34% -$88.1K ﹤0.01% 2477
2025
Q2
$219K Buy
5,310
+222
+4% +$9.99K ﹤0.01% 2634
2025
Q1
$255K Buy
5,088
+154
+3% +$7.61K ﹤0.01% 2480
2024
Q4
$273K Sell
4,934
-1,525
-24% -$69.3K ﹤0.01% 2550
2024
Q3
$214K Sell
6,459
-2,608
-29% -$73.3K ﹤0.01% 2564
2024
Q2
$241K Buy
+9,067
New +$305K ﹤0.01% 2443
2023
Q4
Sell
-12,903
Closed -$217K 2910
2023
Q3
$217K Sell
12,903
-2,860
-18% -$50.6K ﹤0.01% 2378
2023
Q2
$285K Buy
15,763
+4,141
+36% +$65.8K ﹤0.01% 2174
2023
Q1
$149K Buy
+11,622
New +$170K ﹤0.01% 2445

Other funds holding TARS